parkinson.
Conditions
Interventions
Intervention 1: Intervention group: Twenty-two people in the intervention group (including daily two capsules of omega-3 capsules with an EPA of 180mg and DHA of 120mg from the Zahravi Pharmaceuticals
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
50 Years to 70 Years
Inclusion criteria
Inclusion criteria: Those who have Parkinson's diagnosis by a neurologist Those aged 50-70 People who do not use aspirin or another anticoagulant, or statin
Exclusion criteria
Exclusion criteria: Unwillingness to cooperate Patients who already took Omega-3 (6 months ago) Patients who have depression or psychosis or have another inflammatory disease Patients who are unable to take supplementation due to digestive problems or allergic reactions Patients who smoke and drink alcohol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum levels of IL-1B. Timepoint: The beginning and the end of the study. Method of measurement: ELISA KIT.;Serum levels of IL-6. Timepoint: The beginning and the end of the study. Method of measurement: ELISA KIT.;Serum levels of TNF-a. Timepoint: The beginning and the end of the study. Method of measurement: ELISA KIT.;Serum levels of IL-10. Timepoint: The beginning and the end of the study. Method of measurement: ELISA KIT.;Serum levels of TG. Timepoint: The beginning and the end of the study. Method of measurement: LBL KIT.;Serum levels of HDL. Timepoint: The beginning and the end of the study. Method of measurement: LBL KIT.;Serum levels of LDL. Timepoint: The beginning and the end of the study. Method of measurement: By the formula. | — |
Secondary
| Measure | Time frame |
|---|---|
| Check for food. Timepoint: At first and during the study. Method of measurement: A 24-hour recall questionnaire and MNA questionnaire MNA.;Physical activity review. Timepoint: At the beginig of the study. Method of measurement: RAPA questionnaire.;Anthropometric Indicators. Timepoint: The beginning and the end of the study. Method of measurement: Impedance bi-electric system.;BMI. Timepoint: The beginning and the end of the study. Method of measurement: By the formula.;Serum Alb level. Timepoint: Beginning of study. Method of measurement: Enzymatic. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Bahram Pourghasem Gargari
Tabriz University of Medical Sciences
Outcome results
None listed